New revised FIGO 2008 staging system for endometrial cancer produces better discrimination in survival compared with the 1988 staging system

Journal of Surgical Oncology

Volumn 106, Issue 8, 2012, Pages 938-941

  Kato, Tatsuya ^a   Watari, Hidemichi ^a   Endo, Daisuke ^a   Mitamura, Takashi ^a   Odagiri, Tetsuji ^a   Konno, Yousuke ^a   Hosaka, Masayoshi ^a   Kobayashi, Noriko ^a   Todo, Yukiharu ^b   Sudo, Satoko ^a   Takeda, Mahito ^a   Dong, Peixin ^a   Kaneuchi, Masanori ^a   Kudo, Masataka ^a   Sakuragi, Noriaki ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HOKKAIDO CANCER CENTER   (Japan)

Author keywords

endometrial cancer; revised FIGO 2008 staging system; surgical staging; survival

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; PACLITAXEL;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER STAGING; COMPARATIVE STUDY; ENDOMETRIUM CANCER; FEMALE; FIGO 1988 STAGING SYSTEM; FIGO 2008 STAGING SYSTEM; HUMAN; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PARA AORTIC LYMPHADENECTOMY; PELVIS LYMPHADENECTOMY; PRIORITY JOURNAL; SURVIVAL RATE;

ADULT; AGED; AORTA; ENDOMETRIAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODE EXCISION; MIDDLE AGED; NEOPLASM STAGING; PELVIS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84869489106     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23203     Document Type: Article

References (17)

1. Pecorelli S,: Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet 2009; 105: 103-104.
2. Watari H, Todo Y, Takeda M, et al.: Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer. Gynecol Oncol 2005; 96: 651-657.
3. Nagase S, Katabuchi H, Hiura M, et al.: Evidence-based guidelines for treatment of uterine body neoplasm in Japan: Japan Society of Gynecologic Oncology (JSGO) 2009 edition. Int J Clin Oncol 2010; 15: 531-542.
4. Lewin SN, Herzog TJ, Barrena Medel NI, et al.: Comparative performance of the 2009 International Federation of Gynecology and Obstetrics' Staging System for uterine corpus cancer. Obstet Gynecol 2010; 116: 1141-1149.
5. Cooke EW, Pappas L, Gaffney DK,: Does the revised International Federation of Gynecology and Obstetrics staging system for endometrial cancer lead to increased discrimination in patient outcomes? Cancer 2011; 117: 4231-4237.
6. Abu-Rustum NR, Zhou Q, Iasonos A, et al.: The revised 2009 FIGO staging system for endometrial cancer: Should the 1988 FIGO stages IA and IB be altered? Int J Gynecol Cancer 2011; 21: 511-516.
7. Chan JK, Cheung MK, Huh WK, et al.: Therapeutic role of lymph node resection in endometrioid corpus cancer: A study of 12,333 patients. Cancer 2006; 107: 1823-1830.
8. Fujimoto T, Nanjyo H, Nakamura A, et al.: Para-aortic lymphadenectomy may inprove disease-related survival in patients with multipositive pelvic lymph node stage IIIc endometrial cancer. Gynecol Oncol 2007; 107: 253-259.
9. Chang SJ, Kim WY, Yoo SC, et al.: Para-aortic lymphadenectomy improves survival in patients with intermediate to high-risk endometrial carcinoma. Acta Obstet Gynecol Scand 2008; 87: 1361-1369.
10. Todo Y, Kato H, Kaneuchi M, et al.: Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): A retrospective cohort analysis. Lancet 2010; 375: 1165-1172.
11. Kitchener H, Swart AM, Qian Q, et al.: Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): A randomised study. Lancet 2009; 373: 125-136.
12. Benedetti Panici P, Basile S, Maneschi F, et al.: Systematic pelvic lymphadenectomy vs no lymphadenectomy in early stage endometrial carcinoma: Randomized clinical trial. J Natl Cancer Inst 2008; 100: 707-716.
13. Watari H, Mitamura T, Moriwaki M, et al.: Survival and failure pattern of patients with endometrial cancer after extensive surgery including systematic pelvic and para-aortic lymphadenectomy followed by adjuvant chemotherapy. Int J Gynecol Cancer 2009; 19: 1585-1590.
14. Mariani A, Webb MJ, Keeney GL, et al.: Low-risk corpus cancer: Is lymphadenectomy or radiotherapy necessary? Am J Obstet Gynecol 2000; 182: 1506-1519.
15. Lee JY, Jung DC, Park SH, et al.: Preoperative prediction model of lymph node metastasis in endometrial cancer. Int J Gynecol Cancer 2010; 20: 1350-1355.
16. Creasman WT, Morrow CP, Bundy BN, et al.: Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer 1987; 60 (8 Suppl.): 2035-2041.
17. Todo Y, Okamoto K, Hayashi M, et al.: A validation study of a scoring system to estimate the risk of lymph node metastasis for patients with endometrial cancer for tailoring the indication of lymphadenectomy. Gynecol Oncol 2007; 104: 623-628.